Abaluck, J. ; Adams, A. What do consumers consider before they choose? Identification from asymmetric demand responses. 2017 NBER Work. Pap.. -
Allcott, H. Social norms and energy conservation. 2011 J. Publ. Econ.. 95 1082-1095
Baicker, K. ; Mullainathan, S. ; Schwartzstein, J. Behavioral hazard in health insurance. 2015 Q. J. Econ.. 130 1623-1667
Bertrand, M. ; Karlan, D. ; Mullainathan, S. ; Shafir, E. ; Zinman, J. What's advertising content worth? Evidence from a consumer credit marketing field experiment. 2010 Q. J. Econ.. 125 263-306
Bordalo, P. ; Gennaioli, N. ; Shleifer, A. Salience theory of choice under risk. 2012 Q. J. Econ.. 127 1243-1285
Brekke, K.R. ; Canta, C. ; Straume, O.R. Reference pricing with endogenous generic entry. 2016 J. Health Econ.. 50 312-329
Brekke, K.R. ; Holmas, T.H. ; Straume, O.R. Reference pricing, competition, and pharmaceutical expenditures: theory and evidence from a natural experiment. 2011 J. Publ. Econ.. 95 624-638
Carone, G., Schwierz, C., Xavier, A., 2012. Cost-Containment Policies in Public Pharmaceutical Spending in the EU, European Economy, Economic Papers 461. doi:10.2765/27111.
Chetty, R. Behavioral economics and public policy: a pragmatic perspective. 2015 Am. Econ. Rev. Pap. Proc.. 105 1-33
Dalen, D.M. ; Furu, K. ; Locatelli, M. ; Strøm, S. Generic substitution: micro evidence from register data in Norway. 2011 Eur. J. Heal. Econ.. 12 49-59
Danzon, P.M. ; Chao, L. Does regulation drive out competition in pharmaceutical markets?. 2000 J. Law Econ.. 43 311-358
- Decollogny, A. ; Eggli, Y. ; Halfon, P. ; Lufkin, T.M. Determinants of generic drug substitution in Switzerland. 2011 BMC Health Serv. Res.. 11 17-
Paper not yet in RePEc: Add citation now
Dubé, J.-P. ; Hitsch, G.J. ; Rossi, P.E. State dependence and alternative explanations for consumer inertia. 2010 RAND J. Econ.. 41 417-445
Ericson, K.M.M. Consumer inertia and firm pricing in the medicare part d prescription drug insurance exchange. 2014 Am. Econ. J. Econ. Policy. 6 38-64
- Frank, R.E. Brand choice as a probability process. 1962 J. Bus.. 35 43-56
Paper not yet in RePEc: Add citation now
- Frank, R.G. ; Salkever, D.S. Pricing, patent loss and the market for pharmaceuticals. 1992 South. Econ. J.. 59 165-179
Paper not yet in RePEc: Add citation now
Handel, B. Adverse selection and inertia in health insurance markets: when nudging hurts. 2013 Am. Econ. Rev.. 103 2643-2682
Hastings, J.S. ; Shapiro, J.M. Fungibility and consumer choice: evidence from commodity price shocks. 2013 Q. J. Econ.. 128 1449-1498
- Heckman, J.J. The incidental parameters problem and the problem of initial condition in estimating a discrete time-discrete data stochastic process. 1981 En : Manski, C.F. ; McFadden, D.L. Structural Analysis of Discrete Data With Econometric Applications. MIT Press: Cambridge
Paper not yet in RePEc: Add citation now
Heiss, F., Mcfadden, D., Winter, J., Wuppermann, A., Zhou, B., 2016. Inattention and Switching Costs as Sources of Inertia in Medicare Part D. NBER Work. Pap. 22765. doi:10.3386/w22765.
Ho, K. ; Hogan, J. ; Scott Morton, F. The impact of consumer inattention on insurer pricing in the Medicare Part D program. 2017 RAND J. Econ.. 48 877-905
Hole, A.R. Fitting mixed logit models by using maximum simulated likelihood. 2007 Stata J.. 7 388-401
Hortaçsu, A. ; Madanizadeh, S.A. ; Puller, S.L. Power to choose? An analysis of consumer inertia in the residential electricity market. 2017 Am. Econ. J. Econ. Policy. 9 192-226
Iizuka, T. Physician agency and adoption of generic pharmaceuticals. 2012 Am. Econ. Rev.. 102 2826-2858
- Japanese Institute of Life Insurance 2018. Survey Report on Japanese Institute of Life Insurance.
Paper not yet in RePEc: Add citation now
Kahneman, D. ; Wakker, P.P. ; Sarin, R. Back to bentham? explorations of experienced utility. 1997 Q. J. Econ.. 112 375-406
Keane, M.P. Modeling heterogeneity and state dependence in consumer choice behavior. 1997 J. Bus. Econ. Stat.. 15 310-327
- Kesselheim, A.S. ; Misono, A.S. ; Lee, J.L. ; Stedman, M.R. ; Brookhart, A.M. ; Choudhry, N.K. ; Shrank, W.H. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease. 2008 JAMA. 300 2514-2526
Paper not yet in RePEc: Add citation now
Madrian, B.C. ; Shea, D.F. The power of suggestion: inertia in 401(k) participation and savings behavior. 2001 Q. J. Econ.. 116 1149-1187
- Massy, W.F. Order and homogeneity of family specific brand-switching processes. 1966 J. Mark. Res.. 3 48-54
Paper not yet in RePEc: Add citation now
- Ministry of Health, Labour and Welfare, 2016. NDB Open Data [WWW Document]. URLhttp://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000139390.html(accessed 5.1.18).
Paper not yet in RePEc: Add citation now
- Ministry of Health, Labour and Welfare, 2017c. Report on the Effects and Implementation of Generic Drug Promotion Policies.
Paper not yet in RePEc: Add citation now
- Ministry of Health, Labour and Welfare, 2018a. Prescription Drugs Covered by Health Insurance (in Japanese) [WWW Document]. URLhttps://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000078916.html(accessed 8.30.18).
Paper not yet in RePEc: Add citation now
- Ministry of Health, Labour and Welfare, 2018b. Various Information of Medical Fee (in Japanese) [WWW Document]. URLhttp://www.iryohoken.go.jp/shinryohoshu/downloadMenu/
Paper not yet in RePEc: Add citation now
- Pechlivanoglou, P. ; van der Veen, W.J. ; Bos, J.H. ; Postma, M.J. Analyzing generic and branded substitution patterns in the Netherlands using prescription data. 2011 BMC Health Serv. Res.. 11 89-
Paper not yet in RePEc: Add citation now
Polyakova, M. Regulation of insurance with adverse selection and switching costs: evidence from Medicare Part D. 2016 Am. Econ. J. Appl. Econ.. 8 165-195
- Quan, H. ; Li, B. ; Couris, C.M. ; Fushimi, K. ; Graham, P. ; Hider, P. ; Januel, J.M. ; Sundararajan, V. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. 2011 Am. J. Epidemiol.. 173 676-682
Paper not yet in RePEc: Add citation now
Scherer, F.M. The pharmaceutical industry. 2000 En : Cuyler, A.J. ; Newhouse, J.P. Handbook of Health Economics. Elsevier: North Holland, Amsterdam
- Seetharaman, P.B. ; Ainslie, A. ; Chintagunta, P.K. Investigating household state dependence effects across categories. 1999 J. Mark. Res.. 36 488-500
Paper not yet in RePEc: Add citation now
Skipper, N. ; Vejlin, R. Determinants of generic vs. brand drug choice: evidence from population-wide Danish data. 2015 Soc. Sci. Med.. 130 204-215
Strombom, B.A. ; Buchmueller, T.C. ; Feldstein, P.J. Switching costs, price sensitivity and health plan choice. 2002 J. Health Econ.. 21 89-116
Takizawa, O. ; Urushihara, H. ; Tanaka, S. ; Kawakami, K. Price difference as a predictor of the selection between brand name and generic statins in Japan. 2015 Health Policy. 119 612-619
- Thaler, R.H. ; Sunstein, C.R. Nudge: Improving Decisions About Health, Wealth, and Happiness. 2008 Yale University Press: New Haven
Paper not yet in RePEc: Add citation now
Train, K. Discrete Choice Methods With Simulation. 2003 Cambridge University Press: Cambridge